Identification of a 4-fluorobenzyl l-valinate amide benzoxaborole (AN11736) as a potential development candidate for the treatment of Animal African Trypanosomiasis (AAT).
Bioorg Med Chem Lett
; 28(1): 6-10, 2018 01 01.
Article
in En
| MEDLINE
| ID: mdl-29169674
ABSTRACT
Novel l-valinate amide benzoxaboroles and analogues were designed and synthesized for a structure-activity-relationship (SAR) investigation to optimize the growth inhibitory activity against Trypanosoma congolense (T. congolense) and Trypanosoma vivax (T. vivax) parasites. The study identified 4-fluorobenzyl (1-hydroxy-7-methyl-1,3-dihydrobenzo[c][1,2]oxaborole-6-carbonyl)-l-valinate (5, AN11736), which showed IC50 values of 0.15â¯nM against T. congolense and 1.3â¯nM against T. vivax, and demonstrated 100% efficacy with a single dose of 10â¯mg/kg against both T. congolense and T. vivax in mouse models of infection (IP dosing) and in the target animal, cattle, dosed intramuscularly. AN11736 has been advanced to early development studies.
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Trypanosomiasis, African
/
Valine
/
Boron Compounds
/
Antiprotozoal Agents
Type of study:
Diagnostic_studies
Limits:
Animals
Language:
En
Year:
2018
Type:
Article